Analysen von Charles Pitman-King
| 01.10.25 | Sartorius Stedim Biotech Overweight | Barclays Capital | |
| 01.10.25 | Sartorius vz. Overweight | Barclays Capital | |
| 23.07.25 | Sartorius vz. Overweight | Barclays Capital | |
| 18.06.25 | Sartorius vz. Overweight | Barclays Capital | |
| 12.05.25 | Merck Overweight | Barclays Capital | |
| 26.02.25 | Sartorius vz. Overweight | Barclays Capital |